Shionogi logo

Shionogi

Asia, Osaka, Japan, Osaka-shi

Description

Shionogi is a pharmaceutical company that offers pharmaceuticals, diagnostic reagents, and medical devices.

Investor Profile

Shionogi has made 5 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (40%)
  • Series C (20%)
  • Series D (20%)
  • Corporate Round (20%)

Country Focus

  • United States (40%)
  • Japan (40%)
  • France (20%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Health Diagnostics
  • Neuroscience
  • Service Industry
  • Business Information Systems
  • Document Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shionogi frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
Fearless Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 1
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
A. M. Pappas & Associates
North America, North Carolina, United States, Durham
Co-Investments: 1
Evidity Health Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Shionogi often collaborate with?

David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by Shionogi?

CILcare

Montpellier, Languedoc-Roussillon, France

CILcare specializes in providing drug solutions for hearing and ear disorders.

ConsultingHealth CareTherapeutics
Series ADec 4, 2024
Amount Raised: $42,049,050
Avita

Tokyo, Tokyo, Japan

Avita is a software development company that develops and creates role-playing support avatars using generative AI.

Augmented RealityGenerative AIVirtual Reality
Series AAug 23, 2024
Amount Raised: $9,489,835
Akili Interactive Labs

Boston, Massachusetts, United States

Akili Interactive Labs Provides Healthcare Treatments.

BiotechnologyHealth CareMedicalNeuroscienceService IndustryTherapeutics
Series DMay 26, 2021
Amount Raised: $110,000,000
PeptiStar

Settsu, Osaka, Japan

PeptiStar continually strives to develop novel manufacturing technologies to address needs in every stage of the peptide value chain.

Business Information SystemsDocument ManagementInformation ServicesManufacturing
Corporate RoundApr 18, 2018
Amount Raised: $186,286,291
Peninsula Pharmaceuticals

Alameda, California, United States

A bio­pharmaceuti­cal company focused on the devel­opment and com­mer­cializa­tion of antibi­otics.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedical
Series CJan 16, 2004
Amount Raised: $57,900,000